British Axial Spondyloarthritis Inception Cohort

Recruiting now

Conditions studied: Axial Spondyloarthritis

In brief

The British Axial Spondyloarthritis Cohort (BAxSIC) study has been established under the auspices of the British Society for Spondyloarthritis (BRITSpA) in collaboration with the National Axial Spondyloarthritis Society (NASS) to provide real-world data to evaluate the impact of delay in diagnosis (from symptom onset to diagnosis) on work participation and functional outcomes and the natural history and impact of newly-diagnosed axial Spondyloarthritis, including disease activity, pain, fatigue, functional and work outcomes, comorbidities, therapies in the United Kingdom (UK). The study is a prospective cohort, enrolling patients attending rheumatology clinics in the UK who are newly diagnosed with axial Spondyloarthritis and naïve to biologic therapy. The study will run for an initial 3 year period commencing January 2023. Financial support was provided as a Research Grant from Pfizer Limited, UCB and Novartis.

Key facts

Study ID

NCT05676775

Run by

The Leeds Teaching Hospitals NHS Trust

People needed

500

Starts

2023-06-09

Expected to finish

2029-01-09

Last updated by the study team

2023-07-18

Who can join

Age: 16 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged ≥16 years.
• A physician diagnosis of axSpA (including ankylosing spondylitis) within the last 6 months prior to baseline.
• Willing and able to give informed consent to participate in the study.

You may not qualify if…

• Age <16 years.
• Unable to communicate in English or are deemed, in any other way, to be unable to give informed consent

Where it is running

• Chapel Allerton Hospital — Leeds, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.